34 reports of this reaction
2.7% of all ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL reports
#5 most reported adverse reaction
HEADACHE is the #5 most commonly reported adverse reaction for ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL, manufactured by Lil' Drug Store Products, Inc.. There are 34 FDA adverse event reports linking ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL to HEADACHE. This represents approximately 2.7% of all 1,275 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 34 FDA reports for ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.7% of all adverse event reports for ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL, making it a notable side effect.
If you experience headache while taking ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.